LH — Labcorp Holdings Income Statement

0.000.00%

Last trade - 00:00

HealthcareConservativeLarge CapNeutral

Annual income statement for Labcorp Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	R2021 December 31st	R2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	13,136	11,864	12,162	13,009	13,952
Cost of Revenue
Gross Profit	4,992	3,709	3,365	3,624	4,013
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	10,088	10,427	11,436	11,922	12,567
Operating Profit	3,049	1,437	726	1,087	1,385
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	2,888	1,237	569	960	1,108
Provision for Income Taxes
Net Income After Taxes	2,198	1,004	380	747	878
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	2,377	1,279	418	746	877
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	2,377	1,279	418	746	877
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	22.7	13.7	7.37	9.25	11.7
Dividends per Share